Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 24, Issue 4, Pages 501-511
Publisher
SAGE Publications
Online
2017-04-06
DOI
10.1177/1352458517703802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing
- (2016) Raghavan Chinnadurai et al. STEM CELLS
- Bone Marrow Mesenchymal Stromal Cells Isolated from Multiple Sclerosis Patients have Distinct Gene Expression Profile and Decreased Suppressive Function Compared with Healthy Counterparts
- (2015) Gislane L. V. De Oliveira et al. CELL TRANSPLANTATION
- Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis
- (2014) Sara Llufriu et al. PLoS One
- Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?
- (2014) Guido Moll et al. STEM CELLS
- Actin Cytoskeletal Disruption following Cryopreservation Alters the Biodistribution of Human Mesenchymal Stromal Cells In Vivo
- (2014) Raghavan Chinnadurai et al. Stem Cell Reports
- Mesenchymal stem cell transplantation in multiple sclerosis
- (2013) Jeffrey A. Cohen JOURNAL OF THE NEUROLOGICAL SCIENCES
- A randomized trial of mesenchymal stem cells in multiple system atrophy
- (2012) Phil Hyu Lee et al. ANNALS OF NEUROLOGY
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
- (2012) Peter Connick et al. LANCET NEUROLOGY
- Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
- (2012) Manoj M. Lalu et al. PLoS One
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
- (2011) Moïra François et al. CYTOTHERAPY
- Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis
- (2011) Violaine K. Harris et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis
- (2010) Dimitrios Karussis et al. ARCHIVES OF NEUROLOGY
- Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study
- (2010) Bassem Yamout et al. JOURNAL OF NEUROIMMUNOLOGY
- The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group
- (2010) Mark S Freedman et al. Multiple Sclerosis Journal
- Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis
- (2010) Elizabeth Mallam et al. Multiple Sclerosis Journal
- Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment
- (2008) Benedetta Mazzanti et al. JOURNAL OF NEUROIMMUNOLOGY
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
- (2008) Katarina Le Blanc et al. LANCET
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started